Real-World Study of Woven EndoBridge for Intracranial Aneurysm Treatment (NCT07620626) | Clinical Trial Compass
RecruitingNot Applicable
Real-World Study of Woven EndoBridge for Intracranial Aneurysm Treatment
China1,000 participantsStarted 2026-06-10
Plain-language summary
We designed the Real-World Study of Woven EndoBridge for Intracranial Aneurysm Treatment (WEB-RWS), an ambidirectional, multicenter, post-market real-world study with a prospective active surveillance component. The study will include patients with IAs treated with commercially available WEB devices under the direction of treating physicians in routine clinical practice. Clinical, procedural, imaging, and safety data will be collected using a standardized electronic data capture system, with safety events adjudicated by an independent clinical events committee and imaging outcomes assessed by an independent core laboratory. The primary objective is to evaluate 12-month adequate aneurysm occlusion and major adverse events after WEB treatment. The study is expected to provide comprehensive post-market evidence on the real-world performance of the WEB device in China, including its safety, effectiveness, clinical appropriateness, and health economic value in routine neurointerventional practice.
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Retrospective Cohort:
* Participants of any age and sex.
* Patients treated for an intracranial aneurysm using a commercially available MicroVention Woven EndoBridge device.
* Patients who completed at least one postoperative imaging follow-up.
Prospective Cohort:
* Participants of any age and sex.
* Patients treated for an intracranial aneurysm using a commercially available MicroVention Woven EndoBridge device.
* The participant, or legally authorized representative if applicable, understands the study requirements and procedures and provides written informed consent before any study-specific data collection.
Exclusion Criteria:
Retrospective Cohort:
* Patients treated with a Woven EndoBridge device for whom intraoperative or postoperative follow-up imaging data are not available.
* Patients considered by the investigator to be unsuitable for participation in this study.
Prospective Cohort:
* Participants who are currently participating in, or plan to participate during the follow-up period, another clinical study that may affect the results of this study.
* Patients who are currently unable or expected to be unable to complete follow-up.
* Patients with a life expectancy of less than 1 year due to other diseases or conditions.
* Patients considered by the investigator to be unsuitable for participation in this study.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Incidence of Major Adverse Events
Timeframe: Up to 1 Year After the Index Procedure
2
Proportion of Aneurysms With Adequate Occlusion Based on Raymond-Roy Occlusion Classification